Global
EN
Mavedin
Pimobendan
NEW
New
Where to buy
Pimobendan

Mavedin

to the catalogue

Reliable, convenient and simple-to-use veterinary drug with an appealing taste to support your pet in the fight against heart disease insufficiency

  • Relieves the symptoms of heart failure and improves the quality of life of your pet
  • Increases the strength of heart contractions and has a vasodilating effect
  • Accurate dosing due to 3 formats (1.25 mg, 5 mg, 10 mg) and the possibility of dividing the tablet into 4 parts
Composition
Pharmacological properties
Indications
Dosage and method of administration
Restrictions
1 tab Mavedin 1.25 OR 5 OR 10
pimobendan 1.25 mg or 5 mg or 10 mg
Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Pharmacological properties

Pimobendan is a derivative of benzimidazole pyridazinone and has a positive inotropic and vasodilating (vasodilating) effect. Unlike cardiac glycosides, the positive inotropic effect of pimobendan is due to two mechanisms: increased sensitivity of cardiac muscle fibers to calcium and inhibition of phosphodiesterase III (vasodilating effect).
The use of the drug in heart failure increases the strength of heart contractions and reduces preload and postload of the heart.

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Indications

Mavedin is used in dogs

  • for the treatment of heart failure caused by dilated cardiomyopathy (DCM) at the asymptomatic (preclinical) and clinical stages of the disease
  • with myxomatous degeneration of the bicuspid or tricuspid valve at the clinical stage
  • with myxomatous degeneration of the mitral valve at an asymptomatic (preclinical) stage of the disease
Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Dosage and method of administration

Indicators

Dogs

Dosage

0.2-0.6 mg ml per 1 kg of animal body weight daily. The daily dosage is divided into 2 equal dosages.

Method and frequency of administration

Perorally individually 0.5-1 hour before feeding

Treatment period

The dosage of the veterinary drug, the frequency of use and the duration of the course of treatment are set by a veterinarian individually, depending on the indications, the severity of the disease and the condition of the animal.

In case of congestive heart failure, the drug is used in dogs during their whole life with individual dosage selection.

The most convenient is to use Mavedin 1.25 for animals weighing less than 5 kg, Mavedin 5 - for animals weighing from 5 to 20 kg, and Mavedin 10 - for animals weighing from 20 kg.

Animal body weight, kg

Daily dosage, mg

Number of tablets for daily administration

Morning dosage

Evening dosage

1.25 mg

5 mg

10 mg

1.25 mg

5 mg

10 mg

Below 3

0.6

¼

-

-

¼ 

-

-

4-5

1.25

½

-

-

½ 

-

-

5-10

2.25

1

¼

-

1

¼ 

-

11-20

5

2

½

¼

2

½ 

¼ 

21-30

7.5

-

¾ 

½

-

¾ 

½ 

31-40

10

-

1

½

-

1

½ 

41-50

15

-

1 ½ 

¾

-

1 ½ 

3/4

51-60

20

-

2

1

-

2

1

Above 60

30

-

3

1 ½ 

-

3

1 ½ 

The recommended dosage to achieve a clinical effect is 0.5 mg per 1 kg of animal body weight per day.

To more accurately determine the dose corresponding to the body weight of the animal, the tablet can be divided along the score lines.

In case of pimobendan treatment of dogs suffering from diabetes mellitus, a regular monitoring of blood glucose levels is recommended.

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Restrictions

Contraindications and special instructions:
The use of the drug is prohibited:

  • in case of hypertrophic cardiomyopathy and clinical conditions in which cardiac blood output cannot be increased due to functional or anatomical features (for example, aortic stenosis)
  • in case of severe liver damage (due to the process of metabolism of the veterinary drug in this organ)
  • animals with individual hypersensitivity to the components of the veterinary drug
  • the veterinary drug should be used with caution in females during pregnancy and feeding of offspring under the supervision of a veterinarian
Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.